- Home
- MLKN vs HRMY Comparison
MLKN vs HRMY Comparison
Compare MLKN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- HRMY
- Stock Information
- Founded
- MLKN 1905
- HRMY 2017
- Country
- MLKN United States
- HRMY United States
- Employees
- MLKN N/A
- HRMY N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- MLKN Consumer Discretionary
- HRMY Health Care
- Exchange
- MLKN Nasdaq
- HRMY Nasdaq
- Market Cap
- MLKN 1.8B
- HRMY 1.9B
- IPO Year
- MLKN N/A
- HRMY 2020
- Fundamental
- Price
- MLKN $22.55
- HRMY $34.28
- Analyst Decision
- MLKN
- HRMY Buy
- Analyst Count
- MLKN 0
- HRMY 10
- Target Price
- MLKN N/A
- HRMY $49.80
- AVG Volume (30 Days)
- MLKN 1.1M
- HRMY 601.0K
- Earning Date
- MLKN 12-18-2024
- HRMY 10-29-2024
- Dividend Yield
- MLKN 3.35%
- HRMY N/A
- EPS Growth
- MLKN 36.64
- HRMY N/A
- EPS
- MLKN 0.91
- HRMY 2.11
- Revenue
- MLKN $3,593,100,000.00
- HRMY $681,879,000.00
- Revenue This Year
- MLKN $4.04
- HRMY $24.79
- Revenue Next Year
- MLKN $4.16
- HRMY $17.98
- P/E Ratio
- MLKN $24.71
- HRMY $16.28
- Revenue Growth
- MLKN N/A
- HRMY 25.83
- 52 Week Low
- MLKN $20.89
- HRMY $28.14
- 52 Week High
- MLKN $31.73
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- MLKN 34.56
- HRMY 53.15
- Support Level
- MLKN $20.89
- HRMY $33.01
- Resistance Level
- MLKN $25.72
- HRMY $34.82
- Average True Range (ATR)
- MLKN 0.87
- HRMY 1.16
- MACD
- MLKN -0.29
- HRMY 0.12
- Stochastic Oscillator
- MLKN 35.05
- HRMY 71.10
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.